New treatments for multiple sclerosis.
Kilpatrick
T J
TJ
Development and Neurobiology Group, The Walter and Eliza Hall Institute of Medical Research, Parkville, Vic.
Soilu-Hänninen
M
M
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D007372:Interferons